The OPTIMIST study: optimisation of cost effectiveness through individualised FSH stimulation dosages for IVF treatment. A randomised controlled trial

Journal Title: BMC Women's Health - Year 2012, Vol 12, Issue

Abstract

Costs of in vitro fertilisation (IVF) are high, which is partly due to the use of follicle stimulating hormone (FSH). FSH is usually administered in a standard dose. However, due to differences in ovarian reserve between women, ovarian response also differs with potential negative consequences on pregnancy rates. A Markov decision-analytic model showed that FSH dose individualisation according to ovarian reserve is likely to be cost-effective in women who are eligible for IVF. However, this has never been confirmed in a large randomised controlled trial (RCT). The aim of the present study is to assess whether an individualised FSH dose regime based on an ovarian reserve test (ORT) is more cost-effective than a standard dose regime.

Authors and Affiliations

Theodora C van Tilborg, Marinus JC Eijkemans, Joop SE Laven, Carolien AM Koks, Jan Peter de Bruin, Gabrielle J Scheffer, Ron JT van Golde, Kathrin Fleischer, Annemieke Hoek, Annemiek W Nap, Walter KH Kuchenbecker, Petra A Manger, Egbert A Brinkhuis, Arne M van Heusden, Alexander V Sluijmer, Arie Verhoeff, Marcel HA van Hooff, Jaap Friederich, Jesper MJ Smeenk, Janet Kwee, Harold R Verhoeve, Cornelis B Lambalk, Frans M Helmerhorst, Fulco van der Veen, Ben Willem J Mol, Helen L Torrance, Frank JM Broekmans

Keywords

Related Articles

Estimation of menstrual blood loss volume based on menstrual diary and laboratory data

Abnormal uterine bleeding is often investigated in clinical studies and critical to identify during gynecological consultation. The current standard for quantification of menstrual blood loss is the alkaline-hematin-meth...

DNA-testing for BRCA1/2 prior to genetic counselling in patients with breast cancer: design of an intervention study, DNA-direct

Current practice for patients with breast cancer referred for genetic counseling, includes face-to-face consultations with a genetic counselor prior to and following DNA-testing. This is based on guidelines regarding Hun...

The inSIGHT study: costs and effects of routine hysteroscopy prior to a first IVF treatment cycle. A randomised controlled trial

In in vitro fertilization (IVF) and intracytoplasmatic sperm injection (ICSI) treatment a large drop is present between embryo transfer and occurrence of pregnancy. The implantation rate per embryo transferred is only 30...

Hypovitaminosis D and prevalent asymptomatic vertebral fractures in Moroccan postmenopausal women

Hypovitaminosis D is associated to accentuated bone loss. However, association between osteoporotic vertebral fractures (VFs) and vitamin D status has not been clearly established.

Fibroid explants reveal a higher sensitivity against MDM2-inhibitor nutlin-3 than matching myometrium

Spontaneous cessation of growth is a frequent finding in uterine fibroids. Increasing evidence suggests an important role of cellular senescence in this growth control. Deciphering the underlying mechanisms of growth con...

Download PDF file
  • EP ID EP679507
  • DOI  10.1186/1472-6874-12-29
  • Views 46
  • Downloads 0

How To Cite

Theodora C van Tilborg, Marinus JC Eijkemans, Joop SE Laven, Carolien AM Koks, Jan Peter de Bruin, Gabrielle J Scheffer, Ron JT van Golde, Kathrin Fleischer, Annemieke Hoek, Annemiek W Nap, Walter KH Kuchenbecker, Petra A Manger, Egbert A Brinkhuis, Arne M van Heusden, Alexander V Sluijmer, Arie Verhoeff, Marcel HA van Hooff, Jaap Friederich, Jesper MJ Smeenk, Janet Kwee, Harold R Verhoeve, Cornelis B Lambalk, Frans M Helmerhorst, Fulco van der Veen, Ben Willem J Mol, Helen L Torrance, Frank JM Broekmans (2012). The OPTIMIST study: optimisation of cost effectiveness through individualised FSH stimulation dosages for IVF treatment. A randomised controlled trial. BMC Women's Health, 12(), -. https://europub.co.uk/articles/-A-679507